Skyepharma is a fully integrated Contract Development and Manufacturing Organisation (CDMO) specialising in complex oral dosage forms, offering a comprehensive range of services from development to industrial manufacturing and packaging.

With over 25 years of experience, Skyepharma is renowned for its expertise in the formulation, development, and production of complex, modified-release oral solid dosage forms. The company operates a state-of-the-art, FDA-approved GMP facility in France and supports global customers with innovative solutions across various therapeutic areas, including oncology and orphan drugs.

Key Products and Services

• Complex oral solid forms: Multi-layer tablets, mini-tabs, and modified release combinations
• Granules & pellets, tablets, capsules, and blister packaging
• Packaging services: Bottles, blisters, stick-packs, and serialization
• Development services: Formulation challenges and technology transfer
• Manufacturing: Flexible batch sizes and large-scale production
• Regulatory support: Assistance in obtaining and maintaining approvals

Skyepharma continues to provide high-quality, tailor-made solutions for the pharmaceutical industry, ensuring the safe, effective delivery of treatments to patients worldwide.